CorVel Co. (NASDAQ:CRVL) Director Alan Hoops Sells 10,200 Shares

CorVel Co. (NASDAQ:CRVLGet Free Report) Director Alan Hoops sold 10,200 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the transaction, the director now owns 118,213 shares of the company’s stock, valued at $13,758,811.07. This trade represents a 7.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

CorVel Stock Performance

CRVL opened at $108.54 on Friday. The stock’s 50 day moving average price is $123.57 and its 200-day moving average price is $113.48. CorVel Co. has a 52-week low of $76.20 and a 52-week high of $128.61. The stock has a market capitalization of $5.57 billion, a PE ratio of 63.85 and a beta of 1.16.

CorVel (NASDAQ:CRVLGet Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a research report on Tuesday.

Check Out Our Latest Stock Analysis on CRVL

Hedge Funds Weigh In On CorVel

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Mackenzie Financial Corp purchased a new position in CorVel in the 4th quarter worth approximately $848,000. Kolinsky Wealth Management LLC raised its position in shares of CorVel by 200.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 5,205 shares of the business services provider’s stock valued at $579,000 after buying an additional 3,470 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of CorVel by 234.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 93,606 shares of the business services provider’s stock worth $10,415,000 after buying an additional 65,620 shares in the last quarter. Voloridge Investment Management LLC boosted its position in shares of CorVel by 210.8% during the fourth quarter. Voloridge Investment Management LLC now owns 34,775 shares of the business services provider’s stock worth $3,869,000 after acquiring an additional 23,585 shares during the last quarter. Finally, Wolverine Trading LLC grew its stake in CorVel by 266.6% during the fourth quarter. Wolverine Trading LLC now owns 4,550 shares of the business services provider’s stock valued at $511,000 after acquiring an additional 3,309 shares in the last quarter. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

About CorVel

(Get Free Report)

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.

See Also

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.